{
  "schema_version": "0.1.0",
  "case_id": "HR-RB001",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "RB001",
    "display_name": "Evel Knievel",
    "aliases": [
      "Robert Craig Knievel"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1938-10-17",
          "display": "October 17, 1938",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1938",
              "display": "1938",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Associated Press obituary."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "2007-11-30",
          "display": "November 30, 2007",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "2007",
              "display": "2007",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the obituaries and Guinness World Records."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-RB001-SYN",
      "ssn": "000-01-4927",
      "date_of_birth": "1968-10-17",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Dale Rasmussen, MD",
      "fictional_consultant": {
        "name": "Mei-Ling Okonkwo, MD",
        "specialty": "Hepatology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1938-10-17",
        "display": "October 17, 1938",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Robert Craig Knievel in Butte, Montana; raised by his grandparents.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1965",
        "display": "1965",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Begins his daredevil career with a touring motorcycle show.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1968",
        "display": "1968",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Crashes after jumping the fountains at Caesars Palace, Las Vegas, and is hospitalized, by the obituaries' account in a coma for a month.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1974-09-08",
        "display": "September 8, 1974",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Rocket-powered attempt to jump Idaho's Snake River Canyon fails.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1975",
        "display": "1975",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Breaks his pelvis in the crash landing of a jump over 13 buses at Wembley Stadium; Guinness World Records later counts 433 fractures by the end of the year.",
      "claim_ids": [
        "CLM-0003",
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1976",
        "display": "1976",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Concussion and two broken arms in a jump attempt in Chicago; retires from major jumps.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1999",
        "display": "1999",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Liver transplant after nearly dying of hepatitis C, likely acquired through a transfusion after a crash; reported to have stopped drinking at the time of the transplant.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "2007-11-30",
        "display": "November 30, 2007",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at 69 in Clearwater, Florida, of natural causes after years of diabetes, idiopathic pulmonary fibrosis, pain from his injuries and two strokes.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008",
        "CLM-0009"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Robert Craig Knievel was born on October 17, 1938, in the copper-mining town of Butte, Montana, and was raised by his grandparents.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Born Robert Craig Knievel in the copper mining town of Butte on Oct. 17, 1938, Knievel was raised by his grandparents"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster birth year 1938"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "He began his daredevil career in 1965 with a touring motorcycle show. His crash after jumping the fountains at Caesars Palace in Las Vegas, dated 1968 in the wire obituaries, put him in the hospital, by their account in a coma for a month.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "One of the crashes behind the many fractures and the chronic pain in the modern episode. The length of the coma is disputed in later accounts.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "began his daredevil career in 1965; in 1968, when the daredevil crashed his motorcycle spectacularly as he jumped the fountains at Caesar's Palace in Las Vegas and wound up in a coma"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "the crash landing put him in the hospital in a coma for a month"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "He spent almost a month in a coma in 1968"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "In 1974 his rocket-powered cycle failed in an attempt to jump Idaho's Snake River Canyon. In 1975 the crash landing of his jump over 13 buses at Wembley Stadium in London broke his pelvis. In the winter of 1976 an attempt to jump a tank of live sharks in Chicago left him with a concussion and two broken arms, after which he retired from major jumps.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "More of the documented injuries behind the modern pain and fracture history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1974 Snake River Canyon; concussion and broke both arms in an attempt to jump a tank full of live sharks in the Chicago Amphitheater; decided to retire"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "his jump over 13 buses at Wembley Stadium in London; the crash-landing broke his pelvis"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "a brain concussion and two broken arms; retired from major performances"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Guinness World Records lists him as holding the record for the most broken bones in a lifetime, with 433 bone fractures by the end of 1975. His obituaries instead said he suffered nearly 40 broken bones before he retired in 1980.",
      "evidence_grade": "D",
      "certainty": "disputed",
      "clinical_interpretation": "The number of fractures is disputed; that he had very many fractures from crashes is not. The modern episode uses 'dozens of fractures' rather than either number.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Most broken bones in a lifetime: had suffered 433 bone fractures by end of 1975"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "433 fractures by the end of 1975; most broken bones in a lifetime"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "disputes",
          "locator": "He suffered nearly 40 broken bones before he retired in 1980"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster: 433+ bone fractures"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "He had a liver transplant in 1999 after nearly dying of hepatitis C, which his obituaries said he likely contracted through a blood transfusion after one of his crashes.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern episode: transfusion-acquired chronic hepatitis C with advanced liver disease, set three years before the transplant. The stage of his liver disease and any treatment before the transplant were not made public.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "He had undergone a liver transplant in 1999 after nearly dying of hepatitis C, likely contracted through a blood transfusion after one of his many spills"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "liver transplant in 1999 after nearly dying of hepatitis C, likely contracted through a blood transfusion"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "a liver transplant in 1999; likely contracted through a blood transfusion after one of his bone-shattering spills"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster: hepatitis C acquired from blood transfusions; liver transplant"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "A news agency obituary reported that he did not quit drinking until his liver transplant in 1999.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Reported in an obituary; used in the modern episode only as a reason for alcohol counseling in liver disease, with no diagnosis of an alcohol use disorder.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Knievel did not quit drinking until undergoing a liver transplant in 1999"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster: alcohol use disorder (not used as a diagnosis)"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In his last years he was in failing health with diabetes and idiopathic pulmonary fibrosis, an incurable scarring of the lungs, and had two strokes in the years before his death.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His diabetes is documented only in his last years; the modern episode places type 2 diabetes at the index age as a synthetic choice. The lung disease and strokes came after the index age and are not used in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "in failing health for years, suffering from diabetes and idiopathic pulmonary fibrosis, an incurable condition that scarred his lungs; two strokes recently"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "diabetes and idiopathic pulmonary fibrosis"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "two strokes in recent years"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "His final years were plagued by pain from his accidents. In a newspaper interview published early in 2007 he was described as frail and reliant on an oxygen tank and an implanted drug pump to relieve his pain.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Chronic pain from old injuries is documented; the modern episode places it at the index age and manages it without opioids.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "His final years were plagued by pain from his accidents; feeble and reliant on an oxygen tank and an implanted drug pump to relieve his pain"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0009",
      "statement": "He died on November 30, 2007, at 69, at his condominium in Clearwater, Florida, after having trouble breathing; his death was reported as from natural causes.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, stated without detail. The roster's statement that pulmonary fibrosis caused his death is not stated by the obituaries fetched, which give natural causes after years of diabetes and pulmonary fibrosis.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "had trouble breathing at his Clearwater condominium Friday and died before an ambulance could get him to a hospital; natural causes; age 69"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "passed away on 30 November 2007"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "died Friday. He was 69"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster: pulmonary fibrosis caused death"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Stacy M (Associated Press). Evel Knievel, iconic daredevil, dies at 69 of natural causes",
      "publisher": "Lawrence Journal-World",
      "url": "https://www2.ljworld.com/news/2007/dec/01/evel_knievel_iconic_daredevil_dies_69_natural_caus/",
      "source_type": "other",
      "published": "2007-12-01",
      "accessed": "2026-11-04",
      "rights_note": "Wire-service obituary; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Evel Knievel dies at 69; had long been in failing health",
      "publisher": "ESPN.com news services",
      "url": "https://www.espn.co.uk/espn/news/story?id=3135532",
      "source_type": "other",
      "published": "2007-11-30",
      "accessed": "2026-11-04",
      "rights_note": "News obituary drawn from wire reports; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Reuters. Daredevil Evel Knievel dies after long illness",
      "publisher": "Mail & Guardian",
      "url": "https://mg.co.za/2007-12-01-daredevil-evel-knievel-dies-after-long-illness/",
      "source_type": "other",
      "published": "2007-12-01",
      "accessed": "2026-11-04",
      "rights_note": "Wire-service obituary syndicated from Reuters; facts and his quoted words used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Most broken bones in a lifetime",
      "publisher": "Guinness World Records",
      "url": "https://www.guinnessworldrecords.com/world-records/most-broken-bones-in-a-lifetime",
      "source_type": "other",
      "published": "2026",
      "accessed": "2026-11-04",
      "rights_note": "Record entry; the record wording and number used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Selbie J. Stunt legend Evel Knievel's unfortunate record after he broke his bones hundreds of times",
      "publisher": "Guinness World Records",
      "url": "https://www.guinnessworldrecords.com/news/2025/11/stunt-legend-evel-knievels-unfortunate-record-after-he-broke-his-bones-hundreds-of-times",
      "source_type": "other",
      "published": "2025-11-28",
      "accessed": "2026-11-04",
      "rights_note": "Record-keeper news article; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Motorcycle daredevil Evel Knievel dies at 69 (The Associated Press)",
      "publisher": "Deseret News",
      "url": "https://www.deseret.com/2007/11/30/20056581/motorcycle-daredevil-evel-knievel-dies-at-69/",
      "source_type": "other",
      "published": "2007-11-30",
      "accessed": "2026-11-04",
      "rights_note": "Wire-service obituary; used for the wording idiopathic pulmonary fibrosis."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-01-12",
    "index_age": 57,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Find and treat chronic hepatitis C with cirrhosis in a 57-year-old former stunt performer who received many transfusions before 1992: raised transaminases and low platelets prompt hepatitis C antibody with reflex RNA; staging by FIB-4, elastography and ultrasound, with Child-Pugh and MELD-Na; the AASLD-IDSA simplified pathway for compensated cirrhosis with a pan-genotypic regimen (sofosbuvir-velpatasvir for 12 weeks), hepatitis B testing, a drug interaction check (proton pump inhibitor, statin) and hypoglycemia monitoring; cure confirmed by HCV RNA 12 or more weeks after treatment; Baveno VII use of liver stiffness and platelets to identify clinically significant portal hypertension and treat it with carvedilol instead of screening endoscopy; liver cancer surveillance by ultrasound with alpha-fetoprotein every six months that continues after cure; hepatitis A and B vaccination; transplant referral only if decompensation or a MELD-Na of 15 or more develops; pain care that is safe in cirrhosis (acetaminophen up to 2 g a day, no oral NSAIDs, no opioids, topical treatment, physical and aquatic therapy, sleep and coping skills); diabetes care adapted to cirrhosis, with continuous glucose monitoring because the A1c can read falsely low; alcohol counseling toward abstinence; and fall and fracture prevention, with bone density testing, vitamin D and an intravenous bisphosphonate, on the AASLD-IDSA HCV guidance, the AASLD 2023 HCC guidance, Baveno VII, the AASLD portal hypertension and ascites guidance, the ADA Standards of Care and the CMID diabetes and osteoporosis monographs.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-01-12",
        "purpose": "New patient: chronic pain from old fractures, diabetes, and raised liver tests with low platelets on today's tests: hepatitis C and liver work-up, NSAIDs stopped, alcohol counseling, and hepatology review booked"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-01-26",
        "purpose": "Hepatitis C confirmed with compensated cirrhosis: elastography, hepatology consultation, carvedilol for portal hypertension, statin, vaccines, and the antiviral plan"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-02-23",
        "purpose": "Day 1 of sofosbuvir-velpatasvir: drug interaction check, carvedilol titration, glucose monitoring, vitamin D, and the bone density plan"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-05-18",
        "purpose": "End of 12 weeks of antiviral treatment: liver tests, glucose monitoring in cirrhosis, osteoporosis, pain, and abstinence"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-08-17",
        "purpose": "Cure confirmed (SVR12): six-month liver cancer surveillance, cirrhosis care after cure, and transplant criteria reviewed"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-09-21",
        "purpose": "Periodic adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Raised transaminases (ALT 88, AST 96 U/L) and low platelets (118) on today's tests, with spider angiomas and palmar erythema, in a man of 57 who received many blood transfusions after crashes before 1992 and drinks most evenings: chronic liver disease, most likely hepatitis C, must be excluded. Hepatitis C antibody with reflex RNA, hepatitis A and B serology, HIV, liver ultrasound and hepatology review ordered",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R74.01",
            "display": "Elevation of levels of liver transaminase levels",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting problem; no symptom or result of his real illness was made public. Superseded at the hepatology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-01-26"
      },
      {
        "id": "PRB-002",
        "display": "Chronic hepatitis C, genotype 1a, treatment-naive, HCV RNA 2.35 million IU/mL, likely acquired through blood transfusions after crashes; synthetic modern detail linked to his publicly reported transfusion-acquired hepatitis C",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B18.2",
            "display": "Chronic viral hepatitis C",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic genotype, viral load and timing; his hepatitis C and its likely transfusion source are documented (D).",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-01-26",
        "abatement_date": "2026-08-17"
      },
      {
        "id": "PRB-003",
        "display": "Compensated cirrhosis from hepatitis C, with alcohol as a cofactor: liver stiffness 26.8 kPa, FIB-4 4.94, nodular liver and a 14.2 cm spleen on ultrasound, platelets 118; Child-Pugh A5, MELD-Na 8; no ascites, encephalopathy, jaundice or bleeding",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K74.69",
            "display": "Other cirrhosis of liver",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic stage of liver disease linked to his documented hepatitis C and later liver transplant.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-01-26"
      },
      {
        "id": "PRB-004",
        "display": "Clinically significant portal hypertension in compensated cirrhosis (liver stiffness 25 kPa or more), treated with carvedilol without screening endoscopy (Baveno VII)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K76.6",
            "display": "Portal hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding at the hepatology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-01-26"
      },
      {
        "id": "PRB-005",
        "display": "Type 2 diabetes on metformin, A1c 7.4%",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.65",
            "display": "Type 2 diabetes mellitus with hyperglycemia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic; diabetes is documented only in his last years (D), and placing it at 57 is a synthetic choice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-006",
        "display": "Chronic pain in the back, hips, pelvis and knees after dozens of fractures from stunt crashes, including a broken pelvis; ibuprofen stopped, and managed without oral NSAIDs or opioids",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G89.29",
            "display": "Other chronic pain",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic pain at the index age, anchored to his documented fractures and the pain of his later years.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-007",
        "display": "Osteoporosis in a man with cirrhosis, prior heavy alcohol use and dozens of old fractures: femoral neck T-score -2.6, lumbar spine -1.9",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "M81.8",
            "display": "Other osteoporosis without current pathological fracture",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic bone density result.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-18"
      },
      {
        "id": "PRB-008",
        "display": "Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E55.9",
            "display": "Vitamin D deficiency, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding before the bone density scan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-02-23",
        "abatement_date": "2026-05-18"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "861004",
            "display": "metformin hydrochloride 1000 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with breakfast and supper"
        },
        "start_date": "2021-03-01",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic long-standing diabetes treatment; continued in compensated cirrhosis with normal kidney function once he stops drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Ibuprofen 800 mg oral tablet, one tablet three times a day for joint and back pain",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197807",
            "display": "ibuprofen 800 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet three times a day"
        },
        "start_date": "2024-06-01",
        "end_date": "2026-01-12",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic over-the-counter pain treatment, stopped at the first visit because NSAIDs harm the kidneys and raise bleeding risk in liver disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Omeprazole 20 mg delayed-release oral capsule, one capsule daily for indigestion from ibuprofen",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198051",
            "display": "omeprazole 20 MG Delayed Release Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One capsule daily before breakfast"
        },
        "start_date": "2024-06-01",
        "end_date": "2026-01-12",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic acid suppression, stopped with the ibuprofen; it would also interact with velpatasvir.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Acetaminophen 500 mg oral tablet, two tablets by mouth up to twice a day as needed for pain, no more than 2 g a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "Two tablets up to twice a day as needed; no more than 2 g a day"
        },
        "start_date": "2026-01-12",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-line pain relief, limited to 2 g a day because of liver disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Diclofenac sodium 1% topical gel, 4 g to the knees up to four times a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "855633",
            "display": "diclofenac sodium 0.01 MG/MG Topical Gel",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 4,
          "unit": "g"
        },
        "route": "topical",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "4 g to each knee up to four times a day"
        },
        "start_date": "2026-01-12",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic topical anti-inflammatory for knee pain; little reaches the bloodstream, unlike oral NSAIDs.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Carvedilol 6.25 mg oral tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "200031",
            "display": "carvedilol 6.25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-01-26",
        "end_date": "2026-02-23",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic non-selective beta-blocker for clinically significant portal hypertension (Baveno VII).",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Carvedilol 12.5 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "200032",
            "display": "carvedilol 12.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-02-23",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic target dose of carvedilol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Atorvastatin 20 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617310",
            "display": "atorvastatin 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-01-26",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic moderate-intensity statin for diabetes at 57; safe in compensated cirrhosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet, one tablet daily for 12 weeks",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1799212",
            "display": "sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily for 12 weeks"
        },
        "start_date": "2026-02-23",
        "end_date": "2026-05-17",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pan-genotypic antiviral treatment for compensated cirrhosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Cholecalciferol (vitamin D3) 50 mcg (2000 units) oral capsule, one capsule daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "804146",
            "display": "cholecalciferol 0.05 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One capsule daily"
        },
        "start_date": "2026-02-23",
        "indication_problem_ids": [
          "PRB-008"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D replacement.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "MED-011",
        "display": "Zoledronic acid 5 mg in 100 mL, intravenous infusion over at least 15 minutes, once a year",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "705824",
            "display": "100 ML zoledronic acid 0.05 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 5,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 52,
          "period_unit": "wk",
          "text": "Once a year"
        },
        "start_date": "2026-06-01",
        "indication_problem_ids": [
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly bisphosphonate infusion; chosen over an oral bisphosphonate because of portal hypertension and possible varices.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 13.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; low platelets, the first sign of portal hypertension. No result from his life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 4.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; low platelets, the first sign of portal hypertension. No result from his life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 118,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; low platelets, the first sign of portal hypertension. No result from his life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 0.92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 97,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 162,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 88,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 96,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 48
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALKP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 104,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 1.1,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 3.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic metabolic panel; transaminases about twice normal with AST above ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V1",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 1.1,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.9,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic INR for liver function.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 7.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; individual goal below 7%; may read falsely low in cirrhosis"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c on metformin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 186,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel; no statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 112,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99,
          "text": "Goal below 100 mg/dL in diabetes, below 70 if higher risk"
        },
        "interpretation": "H",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel; no statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 38,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "L",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel; no statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 178,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel; no statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 18,
        "unit": "mg/g",
        "reference_range": {
          "high": 29
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly kidney screen in diabetes; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-01-12",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C: three or four drinks most evenings. Sensitive; anchored to the reported drinking before his transplant, not a measured fact of his life.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-01-12",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V1",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-01-12",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic pain score; chronic pain from old fractures.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LSM-V2",
        "display": "Liver stiffness by US.transient elastography",
        "label": "Liver stiffness (transient elastography)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-01-26",
        "value": 26.8,
        "unit": "kPa",
        "reference_range": {
          "high": 7.0,
          "text": "Below 7 kPa normal; above 12.5 kPa cirrhosis; 25 kPa or more clinically significant portal hypertension"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "77615-3",
            "display": "Liver stiffness by US.transient elastography",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic transient elastography at the hepatology visit: cirrhosis with clinically significant portal hypertension.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-01-26",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on the day the diagnosis was explained; item 9 scored 0. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V2",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-01-26",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C two weeks after brief counseling: cutting down. Sensitive.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V2",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-01-26",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score after stopping ibuprofen.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 14.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 4.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 121,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 100,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 141,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 81,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 90,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 48
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 1.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V3",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 3.7,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V3",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 9.1,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before antiviral treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V3",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 17,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D before the bone density scan; deficient, common in cirrhosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V3",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 388,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin B12 on long-term metformin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V3",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 2.1,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH in the secondary-cause work-up for bone loss.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V3",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-02-23",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C: one drink in the past month. Sensitive.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-23",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V3",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-02-23",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score after three weeks of physical therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 14.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 5.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 129,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 0.89,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 100,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 118,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 48
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V4",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 3.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V4",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 9.3,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry at the end of treatment; transaminases normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HCVRNA-V4",
        "display": "Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection",
        "label": "HCV RNA (quantitative)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 0,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 15,
          "text": "Not detected is reported as 0; lower limit of quantification 15 IU/mL"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "11011-4",
            "display": "Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic end-of-treatment HCV RNA: not detected.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 6.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; individual goal below 7%; may read falsely low in cirrhosis"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c; reads lower than the glucose management indicator, as it can in cirrhosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-GMI-V4",
        "display": "Glucose management indicator",
        "label": "Glucose management indicator (14-day CGM)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 6.9,
        "unit": "%",
        "reference_range": {
          "high": 7.0,
          "text": "Individual goal below 7%"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "97506-0",
            "display": "Glucose management indicator",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic glucose management indicator from 14 days of continuous glucose monitoring.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V4",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 34,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D after ten weeks of replacement.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PTH-V4",
        "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
        "label": "Parathyroid hormone (intact)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 48,
        "unit": "pg/mL",
        "reference_range": {
          "low": 15,
          "high": 65
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2731-8",
            "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic parathyroid hormone in the secondary-cause work-up for osteoporosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V4",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Testosterone (morning)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 455,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic morning testosterone in the work-up for osteoporosis in a man.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V4",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-05-18",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C: no alcohol since the start of treatment. Sensitive.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-05-18",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V4",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-05-18",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 14.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count after cure.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 5.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count after cure.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 134,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count after cure.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 0.88,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 100,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 112,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 48
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALKP-V5",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 92,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel 13 weeks after treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V5",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 1.0,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.9,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic INR after cure.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HCVRNA-V5",
        "display": "Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection",
        "label": "HCV RNA (quantitative)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 0,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 15,
          "text": "Not detected is reported as 0; lower limit of quantification 15 IU/mL"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "11011-4",
            "display": "Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic HCV RNA 13 weeks after the last dose: not detected (sustained virologic response).",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AFP-V5",
        "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
        "label": "Alpha-fetoprotein",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 3.4,
        "unit": "ng/mL",
        "reference_range": {
          "high": 8.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1834-1",
            "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alpha-fetoprotein with the six-month surveillance ultrasound.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V5",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 6.3,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; individual goal below 7%; may read falsely low in cirrhosis"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c; glucose control better after cure and abstinence.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-GMI-V5",
        "display": "Glucose management indicator",
        "label": "Glucose management indicator (14-day CGM)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 6.8,
        "unit": "%",
        "reference_range": {
          "high": 7.0,
          "text": "Individual goal below 7%"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "97506-0",
            "display": "Glucose management indicator",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic glucose management indicator from 14 days of continuous glucose monitoring.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V5",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-08-17",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C: abstinent. Sensitive.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-17",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V5",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-08-17",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain score.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V6",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-21",
        "value": 148,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel on atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V6",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-21",
        "value": 68,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99,
          "text": "Goal below 100 mg/dL in diabetes, below 70 if higher risk"
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic LDL cholesterol on atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V6",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-21",
        "value": 42,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HDL cholesterol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V6",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-21",
        "value": 140,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic triglycerides, lower without alcohol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "OBS-PSA-V6",
        "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
        "label": "PSA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-21",
        "value": 1.3,
        "unit": "ng/mL",
        "reference_range": {
          "high": 4.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2857-1",
            "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PSA after shared decision-making.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-21",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Ultrasound of the abdomen with Doppler: nodular liver surface and coarse echotexture; no focal liver lesion; spleen 14.2 cm; portal vein patent with forward flow; no ascites; gallbladder normal",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "45036003",
            "display": "Ultrasonography of abdomen",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-01-19",
          "end": "2026-01-19"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic imaging a week after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Transient elastography (FibroScan) at the hepatology visit: median liver stiffness 26.8 kPa (interquartile range under 30% of the median), controlled attenuation parameter 248 dB/m",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "441491005",
            "display": "Ultrasound elastography of liver",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-01-26",
          "end": "2026-01-26"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic elastography; the coded stiffness is recorded as an imaging result.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Outpatient physical therapy assessment: limited hip and knee range from old fractures, slow gait, Timed Up and Go 13 seconds, poor single-leg balance; aquatic therapy twice a week and a home exercise program; cane for long distances",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "410158009",
            "display": "Physical therapy assessment",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-02",
          "end": "2026-02-02"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic rehabilitation assessment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Dual-energy X-ray absorptiometry: femoral neck T-score -2.6, total hip -2.2, lumbar spine -1.9 (read with caution because of old fractures and degenerative change); 10-year FRAX risk of major osteoporotic fracture 14% and hip fracture 4.1%",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241686001",
            "display": "Dual energy X-ray absorptiometry",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-09",
          "end": "2026-03-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic bone density result.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Surveillance ultrasound of the liver six months after the baseline scan: nodular liver, no focal lesion; spleen 13.8 cm; no ascites (LI-RADS US-1, negative)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "45036003",
            "display": "Ultrasonography of abdomen",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-10",
          "end": "2026-08-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic surveillance imaging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-09-21",
          "end": "2026-09-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only his own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Hepatitis A vaccine, adult, dose 1 of 2",
        "status": "completed",
        "date": "2026-01-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination: hepatitis A IgG negative, and chronic liver disease is an indication.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Hepatitis B vaccine (recombinant, CpG adjuvanted), dose 1 of 2",
        "status": "completed",
        "date": "2026-01-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination: not immune to hepatitis B.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (recombinant, CpG adjuvanted), dose 2 of 2",
        "status": "completed",
        "date": "2026-02-23",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose one month after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis A vaccine, adult, dose 2 of 2",
        "status": "completed",
        "date": "2026-08-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose about seven months after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Influenza vaccine, inactivated, trivalent, preservative free, this season",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccine; chronic liver disease raises the risk of complications.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose: recommended for every adult from 50, and for chronic liver disease and diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult over 50; second dose in two to six months.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Tdap; no dose on record in the past ten years.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Crash after jumping the fountains at Caesars Palace, Las Vegas, with a long hospital stay (reported as a month in a coma)",
        "historical_date": {
          "iso": "1968",
          "display": "1968",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Failed rocket-cycle jump of the Snake River Canyon, Idaho",
        "historical_date": {
          "iso": "1974-09-08",
          "display": "September 8, 1974",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Broken pelvis in the crash landing of a jump over 13 buses at Wembley Stadium, London; Guinness World Records counts 433 fractures by the end of that year (disputed; his obituaries say nearly 40 broken bones in his career)",
        "historical_date": {
          "iso": "1975",
          "display": "1975",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "PMH-004",
        "display": "Concussion and two broken arms in a jump attempt in Chicago; retired from major jumps",
        "historical_date": {
          "iso": "1976",
          "display": "1976",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient: chronic pain from old fractures, diabetes, and raised liver tests with low platelets on today's tests: hepatitis C and liver work-up, NSAIDs stopped, alcohol counseling, and hepatology review booked",
        "status": "finished",
        "date": "2026-01-12",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Hepatitis C confirmed with compensated cirrhosis: elastography, hepatology consultation, carvedilol for portal hypertension, statin, vaccines, and the antiviral plan",
        "status": "finished",
        "date": "2026-01-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Hepatitis C results and hepatology consultation",
          "hpi": {
            "narrative": "Mr. Knievel returns two weeks after his first visit. The hepatitis C antibody was positive and the reflex test found HCV RNA, 2.35 million IU/mL, genotype 1a. Hepatitis B surface antigen, core antibody and surface antibody were all negative, so he has never had hepatitis B and is not immune; hepatitis A IgG was negative; HIV was negative. The ultrasound a week ago showed a nodular liver, a 14.2 cm spleen, no liver mass and no ascites. Dr. Okonkwo of hepatology saw him this morning, and transient elastography in her clinic measured liver stiffness at 26.8 kPa. He stopped ibuprofen and omeprazole after the first visit and uses acetaminophen twice a day and diclofenac gel on his knees; pain is a little worse in the mornings. He has cut down to about two drinks most evenings. He has had no abdominal swelling, black stools, vomiting of blood, confusion or yellow eyes. He has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Hepatitis C",
                "value": "Antibody positive; HCV RNA 2.35 million IU/mL; genotype 1a; never treated"
              },
              {
                "label": "Other serology",
                "value": "Hepatitis B: not infected, not immune. Hepatitis A: not immune. HIV negative"
              },
              {
                "label": "Staging",
                "value": "FIB-4 4.94; liver stiffness 26.8 kPa; nodular liver and 14.2 cm spleen on ultrasound; platelets 118"
              },
              {
                "label": "Liver function",
                "value": "Bilirubin 1.1 mg/dL, albumin 3.6 g/dL, INR 1.1, no ascites or encephalopathy: Child-Pugh A5; MELD-Na 8"
              },
              {
                "label": "Alcohol",
                "value": "Cut down to about two drinks most evenings"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired for months; no fever or weight loss"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or vomiting of blood"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Small red spots on the chest; no yellowing or itching"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion, sleep reversal or tremor"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Hip, knee and back pain, 6 of 10, worse in the mornings since stopping ibuprofen"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried about the diagnosis; PHQ-9 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 85.6 kg; blood pressure 136/82, pulse 78"
            },
            {
              "system": "Eyes",
              "finding": "No scleral icterus"
            },
            {
              "system": "Skin",
              "finding": "Six spider angiomas on the chest and shoulders; palmar erythema; no jaundice or bruising"
            },
            {
              "system": "Abdomen",
              "finding": "Liver edge firm, 2 cm below the costal margin; spleen tip palpable; no shifting dullness"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling"
            },
            {
              "system": "Feet",
              "finding": "Monofilament sensation intact; pulses present; no ulcers"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis; oriented"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic hepatitis C, genotype 1a, treatment-naive",
              "assessment": "Chronic hepatitis C, most likely from transfusions after his crashes before blood was screened for it. He is eligible for the AASLD-IDSA simplified pathway for compensated cirrhosis: no prior treatment, Child-Pugh A, eGFR above 30, hepatitis B surface antigen negative, no known liver cancer and no transplant. Dr. Okonkwo recommends sofosbuvir-velpatasvir, one tablet daily for 12 weeks, to start once it is approved. The interaction check is clean now that omeprazole has stopped; atorvastatin can be used with muscle-pain monitoring",
              "plan": [
                "Sofosbuvir-velpatasvir for 12 weeks when approved",
                "Avoid proton pump inhibitors during treatment; if acid treatment is needed, famotidine up to 40 mg twice a day taken with the tablet or 12 hours apart",
                "HCV RNA 12 or more weeks after the last dose"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Compensated cirrhosis, Child-Pugh A5, MELD-Na 8",
              "assessment": "FIB-4 above 3.25, liver stiffness above 12.5 kPa, a nodular liver, splenomegaly and platelets below 150 all point to cirrhosis, with alcohol as a cofactor. It is compensated. Cirrhosis carries a lifelong risk of liver cancer, so surveillance continues after cure. No transplant evaluation is needed now; referral would follow any decompensation or a MELD-Na of 15",
              "plan": [
                "Ultrasound with alpha-fetoprotein every six months, next in July",
                "Hepatitis A and B vaccines today",
                "Report abdominal swelling, black stools, vomiting of blood, confusion or yellow eyes the same day"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Clinically significant portal hypertension",
              "assessment": "A liver stiffness of 25 kPa or more establishes clinically significant portal hypertension under Baveno VII. A non-selective beta-blocker lowers the risk of decompensation, and carvedilol is preferred; a patient who takes one does not need screening endoscopy for varices",
              "plan": [
                "Carvedilol 6.25 mg daily, raised to 12.5 mg at the next visit if systolic pressure stays above 100",
                "No screening endoscopy while he takes carvedilol"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Type 2 diabetes in cirrhosis",
              "assessment": "A1c 7.4% in January; in cirrhosis the A1c can read falsely low, so a continuous glucose monitor will guide treatment. Metformin is safe in compensated cirrhosis with normal kidney function if he stops drinking. LDL 112 mg/dL: a statin is indicated for diabetes at his age and is safe in compensated cirrhosis",
              "plan": [
                "Atorvastatin 20 mg daily from today",
                "Continuous glucose monitor ordered",
                "Eye examination referral"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Raised transaminases and low platelets",
              "assessment": "Explained by chronic hepatitis C with cirrhosis; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Hepatitis C antibody with reflex HCV RNA and genotype",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Antibody positive; HCV RNA 2.35 million IU/mL; genotype 1a (first-visit sample)",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B surface antigen, core antibody and surface antibody",
              "cadence": "Before any HCV treatment",
              "status": "up_to_date",
              "detail": "All negative: no reactivation risk; vaccinate",
              "guideline_ids": [
                "GL-EPCLUSA-LABEL",
                "GL-AASLD-HCV-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HIV and hepatitis A IgG",
              "cadence": "Before HCV treatment",
              "status": "up_to_date",
              "detail": "HIV negative; hepatitis A not immune",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "FIB-4",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "4.94 from the first-visit results (age 57, AST 96, ALT 88, platelets 118): cirrhosis likely",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Transient elastography",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "26.8 kPa: cirrhosis with clinically significant portal hypertension",
              "observation_ids": [
                "OBS-LSM-V2"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-BAVENO-VII-2022",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver ultrasound",
              "cadence": "Within six months before treatment; every six months in cirrhosis",
              "status": "up_to_date",
              "detail": "A week ago: nodular liver, splenomegaly, no mass, no ascites",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Child-Pugh class and MELD-Na",
              "cadence": "At diagnosis and every six months in cirrhosis",
              "status": "completed_today",
              "detail": "Child-Pugh A5; MELD-Na 8",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of decompensation (ascites, encephalopathy, jaundice, bleeding)",
              "cadence": "Each visit in cirrhosis",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Drug interaction review before HCV treatment",
              "cadence": "Before treatment",
              "status": "completed_today",
              "detail": "Omeprazole and ibuprofen stopped; atorvastatin allowed with monitoring; no amiodarone; no herbal supplements",
              "guideline_ids": [
                "GL-EPCLUSA-LABEL",
                "GL-AASLD-HCV-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Non-selective beta-blocker for clinically significant portal hypertension",
              "cadence": "Start, then titrate to blood pressure and heart rate",
              "status": "completed_today",
              "detail": "Carvedilol 6.25 mg daily started",
              "guideline_ids": [
                "GL-BAVENO-VII-2022",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Screening endoscopy for varices",
              "cadence": "Only if a beta-blocker cannot be taken",
              "status": "not_indicated",
              "detail": "He takes carvedilol, so Baveno VII does not call for screening endoscopy",
              "guideline_ids": [
                "GL-BAVENO-VII-2022",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis A and B vaccination",
              "cadence": "At diagnosis of chronic liver disease if not immune",
              "status": "completed_today",
              "detail": "Hepatitis A dose 1 and hepatitis B (CpG-adjuvanted) dose 1 today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "A1c and glucose monitoring in cirrhosis",
              "cadence": "Every three months when not at goal",
              "status": "up_to_date",
              "detail": "A1c 7.4% in January; continuous glucose monitor ordered because the A1c can read falsely low",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Diabetic foot examination",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "Monofilament sensation and pulses normal",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Diabetic eye examination",
              "cadence": "Yearly",
              "status": "referred",
              "detail": "Referred; last examination over three years ago",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Statin for diabetes",
              "cadence": "Age 40 to 75 with diabetes",
              "status": "completed_today",
              "detail": "Atorvastatin 20 mg started; safe in compensated cirrhosis",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C)",
              "cadence": "Each visit in liver disease",
              "status": "completed_today",
              "detail": "AUDIT-C 4: cutting down; goal is no alcohol",
              "observation_ids": [
                "OBS-AUDITC-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-AASLD-ALD-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and function",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "6 of 10 after stopping ibuprofen; acetaminophen up to 2 g a day and topical diclofenac",
              "observation_ids": [
                "OBS-PAIN-V2"
              ],
              "guideline_ids": [
                "GL-RAKOSKI-2018",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Hepatology",
              "cadence": "At diagnosis of hepatitis C with cirrhosis",
              "status": "completed_today",
              "detail": "Seen this morning; recommendations in the consultation note",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and when treatment changes",
              "status": "completed_today",
              "detail": "PHQ-9 6; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Physical therapy assessment next week. Antiviral treatment to start at the next visit in four weeks, with the second hepatitis B dose and carvedilol titration. Call for abdominal swelling, black stools, vomiting of blood, confusion or yellow eyes",
          "guideline_ids": [
            "GL-AASLD-HCV-2026",
            "GL-AASLD-HCV-MON",
            "GL-EPCLUSA-LABEL",
            "GL-AASLD-HCC-2023",
            "GL-BAVENO-VII-2022",
            "GL-AASLD-PH-2024",
            "GL-AASLD-ASCITES-2021",
            "GL-USPSTF-HCV-2020",
            "GL-USPSTF-ALC-2018",
            "GL-AASLD-ALD-2019",
            "GL-RAKOSKI-2018",
            "GL-CDC-OPIOID-2022",
            "GL-ADA-4-2026",
            "GL-ADA-6-2026",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Day 1 of sofosbuvir-velpatasvir: drug interaction check, carvedilol titration, glucose monitoring, vitamin D, and the bone density plan",
        "status": "finished",
        "date": "2026-02-23",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "First day of hepatitis C treatment",
          "hpi": {
            "narrative": "Mr. Knievel returns four weeks after the hepatology visit to start sofosbuvir-velpatasvir, which has been approved. He takes carvedilol 6.25 mg daily without dizziness. He has had one drink in the past month and wants to stop altogether. He started aquatic therapy three weeks ago and walks a little farther; pain is about 5 of 10. He has taken no omeprazole, ibuprofen or herbal products. He has had no low glucose readings, abdominal swelling, black stools, confusion or yellow eyes. He has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Today",
                "value": "Day 1 of 12 weeks of sofosbuvir-velpatasvir"
              },
              {
                "label": "Carvedilol",
                "value": "6.25 mg daily; pulse 68, blood pressure 128/78"
              },
              {
                "label": "Alcohol",
                "value": "One drink in the past month"
              },
              {
                "label": "Pain",
                "value": "5 of 10 with aquatic therapy"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Still tired in the afternoons; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or heartburn"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No dizziness on standing"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Hip and knee pain, 5 of 10; no muscle aches"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No shakiness or sweating to suggest low glucose"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-9 5; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 84.8 kg; blood pressure 128/78, pulse 68"
            },
            {
              "system": "Skin",
              "finding": "Spider angiomas unchanged; no jaundice or bruising"
            },
            {
              "system": "Abdomen",
              "finding": "Spleen tip palpable; no ascites"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Reduced hip rotation; knee crepitus; old forearm fracture deformities"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic hepatitis C, genotype 1a",
              "assessment": "Pre-treatment tests within three months are complete: platelets 121, creatinine 0.90 mg/dL with eGFR 100, ALT 81, AST 90 U/L, bilirubin 1.0 mg/dL, albumin 3.7 g/dL, and INR 1.1 in January. The interaction check is unchanged. On-treatment liver tests are optional on this pathway; he will call for jaundice, dark urine or abdominal swelling. As the virus clears, glucose can fall, so he will watch his sensor for lows",
              "plan": [
                "Sofosbuvir-velpatasvir one tablet daily from today for 12 weeks; a pill box and phone reminder",
                "Review at the end of treatment",
                "No new medicines or supplements without checking"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Clinically significant portal hypertension",
              "assessment": "Pulse 68 and blood pressure 128/78 on carvedilol 6.25 mg allow the target dose",
              "plan": [
                "Carvedilol 12.5 mg daily from today",
                "Hold a dose and call if systolic pressure falls below 90 or he feels faint"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Vitamin D deficiency",
              "assessment": "25-hydroxyvitamin D 17 ng/mL, common in cirrhosis; calcium 9.1 mg/dL and TSH 2.1 are normal; vitamin B12 388 pg/mL on long-term metformin is normal",
              "plan": [
                "Vitamin D3 2000 units daily",
                "Bone density scan in two weeks",
                "Recheck vitamin D at the end of treatment"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Type 2 diabetes",
              "assessment": "Glucose 141 mg/dL fasting; sensor started today",
              "plan": [
                "Continue metformin",
                "Sensor review at the end of treatment"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Chronic pain from old fractures",
              "assessment": "Better with aquatic therapy; no NSAIDs or opioids",
              "plan": [
                "Continue aquatic therapy twice a week and the home program",
                "Acetaminophen up to 2 g a day; diclofenac gel to the knees"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count, hepatic function panel and eGFR",
              "cadence": "Within three months before HCV treatment",
              "status": "completed_today",
              "detail": "Hemoglobin 14.0 g/dL, white cells 4.8, platelets 121; creatinine 0.90 mg/dL, eGFR 100; ALT 81, AST 90 U/L, bilirubin 1.0 mg/dL, albumin 3.7 g/dL",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-PLT-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3",
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-TBIL-V3",
                "OBS-ALB-V3"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "INR",
              "cadence": "Within three months before HCV treatment",
              "status": "up_to_date",
              "detail": "1.1 in January",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Drug interaction review",
              "cadence": "At the start of HCV treatment",
              "status": "completed_today",
              "detail": "No proton pump inhibitor, amiodarone or supplements; atorvastatin with muscle-pain monitoring",
              "guideline_ids": [
                "GL-EPCLUSA-LABEL",
                "GL-AASLD-HCV-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hypoglycemia monitoring on diabetes medicine during HCV treatment",
              "cadence": "Throughout treatment",
              "status": "completed_today",
              "detail": "Sensor started; he knows how to treat a low",
              "observation_ids": [
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-EPCLUSA-LABEL",
                "GL-AASLD-HCV-2026",
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Carvedilol titration",
              "cadence": "Every two to four weeks to the target dose",
              "status": "completed_today",
              "detail": "Raised to 12.5 mg daily; pulse 68, blood pressure 128/78",
              "guideline_ids": [
                "GL-BAVENO-VII-2022",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis B vaccination, dose 2",
              "cadence": "One month after dose 1",
              "status": "completed_today",
              "detail": "Given today; series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Vitamin D, calcium and TSH (secondary causes of bone loss)",
              "cadence": "Before bone density testing in a man at risk",
              "status": "completed_today",
              "detail": "Vitamin D 17 ng/mL (low); calcium 9.1 mg/dL; TSH 2.1",
              "observation_ids": [
                "OBS-VITD-V3",
                "OBS-CA-V3",
                "OBS-TSH-V3"
              ],
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Vitamin B12 on long-term metformin",
              "cadence": "Periodically",
              "status": "completed_today",
              "detail": "388 pg/mL, normal",
              "observation_ids": [
                "OBS-B12-V3"
              ],
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Men at risk: cirrhosis, alcohol and prior fractures",
              "status": "ordered",
              "detail": "Booked in two weeks",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Physical therapy",
              "cadence": "For falls and chronic pain",
              "status": "up_to_date",
              "detail": "Assessed three weeks ago; aquatic therapy twice a week",
              "guideline_ids": [
                "GL-RAKOSKI-2018",
                "GL-CDC-OPIOID-2022",
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Diabetic eye examination",
              "cadence": "Yearly",
              "status": "referred",
              "detail": "Referral made at the last visit; not yet booked",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of decompensation (ascites, encephalopathy, jaundice, bleeding)",
              "cadence": "Each visit in cirrhosis",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C)",
              "cadence": "Each visit in liver disease",
              "status": "completed_today",
              "detail": "AUDIT-C 1; he plans to stop",
              "observation_ids": [
                "OBS-AUDITC-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-AASLD-ALD-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and function",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "5 of 10; walking farther",
              "observation_ids": [
                "OBS-PAIN-V3"
              ],
              "guideline_ids": [
                "GL-RAKOSKI-2018",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and when treatment changes",
              "status": "completed_today",
              "detail": "PHQ-9 5",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Bone density scan in two weeks. Review at the end of 12 weeks of treatment. Call for jaundice, dark urine, abdominal swelling, black stools, confusion, faintness or low glucose readings",
          "guideline_ids": [
            "GL-AASLD-HCV-2026",
            "GL-AASLD-HCV-MON",
            "GL-EPCLUSA-LABEL",
            "GL-BAVENO-VII-2022",
            "GL-AASLD-PH-2024",
            "GL-AASLD-ASCITES-2021",
            "GL-USPSTF-ALC-2018",
            "GL-AASLD-ALD-2019",
            "GL-RAKOSKI-2018",
            "GL-CDC-OPIOID-2022",
            "GL-ADA-4-2026",
            "GL-ADA-6-2026",
            "GL-ENDO-OSTEO-MEN-2012",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "End of 12 weeks of antiviral treatment: liver tests, glucose monitoring in cirrhosis, osteoporosis, pain, and abstinence",
        "status": "finished",
        "date": "2026-05-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "End of 12 weeks of hepatitis C treatment",
          "hpi": {
            "narrative": "Mr. Knievel finished sofosbuvir-velpatasvir yesterday without missing a dose. He has had no alcohol since the day treatment started. He takes carvedilol 12.5 mg daily without dizziness. His glucose sensor has shown no readings below 70 mg/dL. The bone density scan ten weeks ago showed osteoporosis at the hip. He has had no falls since starting physical therapy, walks 20 minutes on flat ground and swims twice a week; pain is about 4 of 10. He has not yet had his diabetic eye examination because the appointment was not booked after the referral. He saw his dentist last week. He has had no muscle aches, abdominal swelling, black stools, confusion or yellow eyes. He has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Treatment",
                "value": "12 weeks of sofosbuvir-velpatasvir completed; no missed doses"
              },
              {
                "label": "Alcohol",
                "value": "None for 12 weeks"
              },
              {
                "label": "Bone density",
                "value": "Femoral neck T-score -2.6; lumbar spine -1.9"
              },
              {
                "label": "Glucose sensor",
                "value": "Glucose management indicator 6.9%; no lows"
              },
              {
                "label": "Eye examination",
                "value": "Not yet done"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "More energy; weight down 1.6 kg"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or nausea"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Hip and knee pain, 4 of 10; no muscle aches"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low glucose readings"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion or tremor"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 4; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 83.2 kg; blood pressure 118/72, pulse 62"
            },
            {
              "system": "Skin",
              "finding": "Spider angiomas fewer; no jaundice"
            },
            {
              "system": "Abdomen",
              "finding": "Spleen tip palpable; no ascites"
            },
            {
              "system": "Mouth",
              "finding": "Teeth in good repair"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis; gait steady with a cane"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic hepatitis C, genotype 1a, end of treatment",
              "assessment": "Treatment completed with full adherence. HCV RNA is not detected at the end of treatment and ALT 24 and AST 29 U/L are normal; cure is confirmed only by a test 12 or more weeks from now",
              "plan": [
                "HCV RNA and liver tests 12 or more weeks after the last dose, with the six-month ultrasound"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Osteoporosis",
              "assessment": "Femoral neck T-score -2.6 with a 10-year hip fracture risk of 4.1% in a man with cirrhosis, prior heavy alcohol use and dozens of old fractures: treatment is indicated. Secondary causes are addressed: vitamin D now 34 ng/mL, calcium 9.3 mg/dL, parathyroid hormone 48 pg/mL and testosterone 455 ng/dL are normal. An oral bisphosphonate can irritate the esophagus, which is a concern with portal hypertension and possible varices, so a yearly zoledronic acid infusion is preferred. His dental check is done",
              "plan": [
                "Zoledronic acid 5 mg intravenously in two weeks",
                "Calcium from food about 1000 mg a day; continue vitamin D3",
                "Bone density again in two years"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Type 2 diabetes in cirrhosis",
              "assessment": "A1c 6.4% but a glucose management indicator of 6.9%: the A1c reads lower than the true average, as it can in cirrhosis, so the sensor guides treatment. No hypoglycemia on metformin as the virus cleared",
              "plan": [
                "Continue metformin and the sensor",
                "Eye examination booked today for next month"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Clinically significant portal hypertension",
              "assessment": "Pulse 62 and blood pressure 118/72 on carvedilol 12.5 mg",
              "plan": [
                "Continue carvedilol"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Vitamin D deficiency",
              "assessment": "Vitamin D 34 ng/mL after replacement; resolved",
              "plan": [
                "Continue vitamin D3 2000 units daily"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Chronic pain from old fractures",
              "assessment": "4 of 10; walking 20 minutes; no NSAIDs or opioids",
              "plan": [
                "Continue aquatic therapy and the home program"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HCV RNA at the end of treatment",
              "cadence": "Optional at the end of treatment",
              "status": "completed_today",
              "detail": "Not detected",
              "observation_ids": [
                "OBS-HCVRNA-V4"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatic function panel, blood count and kidney function",
              "cadence": "At the end of treatment in cirrhosis, as needed",
              "status": "completed_today",
              "detail": "ALT 24, AST 29 U/L, bilirubin 0.8 mg/dL, albumin 3.9 g/dL; platelets 129, hemoglobin 14.2 g/dL, white cells 5.0; creatinine 0.89 mg/dL, eGFR 100",
              "observation_ids": [
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-TBIL-V4",
                "OBS-ALB-V4",
                "OBS-PLT-V4",
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and side effects",
              "cadence": "During treatment",
              "status": "completed_today",
              "detail": "No missed doses; no side effects; no muscle aches on atorvastatin",
              "guideline_ids": [
                "GL-EPCLUSA-LABEL",
                "GL-AASLD-HCV-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose control in cirrhosis: A1c with sensor data",
              "cadence": "Every three months when therapy changes",
              "status": "completed_today",
              "detail": "A1c 6.4%; glucose management indicator 6.9%; fasting glucose 118 mg/dL; no hypoglycemia",
              "observation_ids": [
                "OBS-A1C-V4",
                "OBS-GMI-V4",
                "OBS-GLU-V4"
              ],
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026",
                "GL-EPCLUSA-LABEL",
                "GL-AASLD-HCV-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Diabetic eye examination",
              "cadence": "Yearly",
              "status": "deferred",
              "detail": "A deviation: referred two visits ago but never booked, because the referral was sent without an appointment request. No harm is known; he has no visual symptoms. Corrective action: booked today for next month, with a reminder to confirm the result",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Men at risk",
              "status": "up_to_date",
              "detail": "Ten weeks ago: femoral neck T-score -2.6, lumbar spine -1.9; FRAX hip fracture risk 4.1%",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Secondary causes of osteoporosis and calcium before zoledronic acid",
              "cadence": "Before starting treatment",
              "status": "completed_today",
              "detail": "Vitamin D 34 ng/mL, calcium 9.3 mg/dL, parathyroid hormone 48 pg/mL, testosterone 455 ng/dL",
              "observation_ids": [
                "OBS-VITD-V4",
                "OBS-CA-V4",
                "OBS-PTH-V4",
                "OBS-TESTO-V4"
              ],
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Dental review before a bisphosphonate",
              "cadence": "Before the first dose",
              "status": "up_to_date",
              "detail": "Seen by his dentist last week",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Carvedilol: blood pressure and heart rate",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "118/72, pulse 62",
              "guideline_ids": [
                "GL-BAVENO-VII-2022",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver ultrasound for cancer surveillance",
              "cadence": "Every six months in cirrhosis",
              "status": "due",
              "detail": "Due in July, six months after the baseline scan",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of decompensation (ascites, encephalopathy, jaundice, bleeding)",
              "cadence": "Each visit in cirrhosis",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Falls and fracture risk",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No falls since physical therapy; cane outdoors",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C)",
              "cadence": "Each visit in liver disease",
              "status": "completed_today",
              "detail": "AUDIT-C 0",
              "observation_ids": [
                "OBS-AUDITC-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-AASLD-ALD-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and function",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "4 of 10",
              "observation_ids": [
                "OBS-PAIN-V4"
              ],
              "guideline_ids": [
                "GL-RAKOSKI-2018",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and when treatment changes",
              "status": "completed_today",
              "detail": "PHQ-9 4",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Zoledronic acid infusion in two weeks. Eye examination next month. Liver ultrasound in July. Review with HCV RNA, liver tests and alpha-fetoprotein 12 or more weeks after the last dose",
          "guideline_ids": [
            "GL-AASLD-HCV-2026",
            "GL-AASLD-HCV-MON",
            "GL-EPCLUSA-LABEL",
            "GL-AASLD-HCC-2023",
            "GL-BAVENO-VII-2022",
            "GL-AASLD-PH-2024",
            "GL-AASLD-ASCITES-2021",
            "GL-USPSTF-ALC-2018",
            "GL-AASLD-ALD-2019",
            "GL-RAKOSKI-2018",
            "GL-CDC-OPIOID-2022",
            "GL-ADA-4-2026",
            "GL-ADA-6-2026",
            "GL-ENDO-OSTEO-MEN-2012",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Cure confirmed (SVR12): six-month liver cancer surveillance, cirrhosis care after cure, and transplant criteria reviewed",
        "status": "finished",
        "date": "2026-08-17",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Test of cure for hepatitis C and six-month liver cancer surveillance",
          "hpi": {
            "narrative": "Mr. Knievel returns 13 weeks after his last dose of sofosbuvir-velpatasvir. The surveillance ultrasound a week ago showed no liver lesion. He had the zoledronic acid infusion eleven weeks ago, with a day of aches afterwards. His eye examination in June showed no diabetic retinopathy. He has had no alcohol since February. He takes carvedilol 12.5 mg daily. Pain is about 4 of 10 and he walks 30 minutes most days. He has had no falls, abdominal swelling, black stools, confusion or yellow eyes. He has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Cure",
                "value": "HCV RNA not detected 13 weeks after treatment"
              },
              {
                "label": "Surveillance",
                "value": "Ultrasound a week ago: no lesion; alpha-fetoprotein 3.4 ng/mL"
              },
              {
                "label": "Liver function",
                "value": "Child-Pugh A5; MELD-Na 6"
              },
              {
                "label": "Bone",
                "value": "Zoledronic acid given eleven weeks ago"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight steady"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or vomiting of blood"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Hip and knee pain, 4 of 10"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion or tremor"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low glucose readings"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 82.6 kg; blood pressure 120/74, pulse 60"
            },
            {
              "system": "Skin",
              "finding": "A few spider angiomas; no jaundice"
            },
            {
              "system": "Abdomen",
              "finding": "Spleen tip palpable; no ascites"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis; gait steady"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Chronic hepatitis C, cured (sustained virologic response)",
              "assessment": "HCV RNA not detected 13 weeks after a 12-week course, with ALT 22 and AST 26 U/L: virologic and biochemical cure. The antibody will stay positive for life, so any future check for reinfection must be an HCV RNA test",
              "plan": [
                "Problem resolved",
                "HCV RNA if liver tests rise or a new exposure occurs"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Compensated cirrhosis after cure",
              "assessment": "Child-Pugh A5 (bilirubin 0.8 mg/dL, albumin 4.0 g/dL, INR 1.0) and MELD-Na 6; platelets 134, rising; FIB-4 now 2.36. Cure lowers but does not remove the risk of liver cancer and decompensation in cirrhosis. No transplant evaluation: there has been no decompensation and the MELD-Na is far below 15",
              "plan": [
                "Ultrasound with alpha-fetoprotein every six months for life; next in February",
                "Liver stiffness and platelets a year after cure, to see whether portal hypertension has improved",
                "No alcohol"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Clinically significant portal hypertension",
              "assessment": "Continue carvedilol until reassessment a year after cure",
              "plan": [
                "Carvedilol 12.5 mg daily"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Type 2 diabetes",
              "assessment": "Glucose management indicator 6.8%, A1c 6.3%, fasting glucose 112 mg/dL; no hypoglycemia; no retinopathy",
              "plan": [
                "Continue metformin and the sensor"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Osteoporosis",
              "assessment": "Zoledronic acid given; no falls",
              "plan": [
                "Next infusion in nine months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HCV RNA 12 or more weeks after treatment (SVR12)",
              "cadence": "Once, 12 or more weeks after the last dose",
              "status": "completed_today",
              "detail": "Not detected: cured",
              "observation_ids": [
                "OBS-HCVRNA-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatic function panel after treatment",
              "cadence": "With the test of cure",
              "status": "completed_today",
              "detail": "ALT 22, AST 26, alkaline phosphatase 92 U/L, bilirubin 0.8 mg/dL, albumin 4.0 g/dL",
              "observation_ids": [
                "OBS-ALT-V5",
                "OBS-AST-V5",
                "OBS-ALKP-V5",
                "OBS-TBIL-V5",
                "OBS-ALB-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count, INR and kidney function in cirrhosis",
              "cadence": "Every six months",
              "status": "completed_today",
              "detail": "Platelets 134, hemoglobin 14.4 g/dL, white cells 5.2; INR 1.0; creatinine 0.88 mg/dL, eGFR 100",
              "observation_ids": [
                "OBS-PLT-V5",
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-INR-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Child-Pugh class and MELD-Na",
              "cadence": "Every six months in cirrhosis",
              "status": "completed_today",
              "detail": "Child-Pugh A5; MELD-Na 6",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver ultrasound for cancer surveillance at six months",
              "cadence": "Every six months in cirrhosis",
              "status": "deferred",
              "detail": "A deviation: due six months after the baseline scan, in July, but done a week ago, about three weeks late, because the recall was set from the hepatology visit and then held until after the test of cure. No harm resulted: no lesion (LI-RADS US-1). Corrective action: the recall is now set from the date of each scan, every six months",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Alpha-fetoprotein with surveillance ultrasound",
              "cadence": "Every six months with ultrasound",
              "status": "completed_today",
              "detail": "3.4 ng/mL",
              "observation_ids": [
                "OBS-AFP-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Next surveillance ultrasound with alpha-fetoprotein",
              "cadence": "Every six months",
              "status": "due",
              "detail": "February",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver stiffness after cure",
              "cadence": "A year after cure (Baveno VII)",
              "status": "due",
              "detail": "Next summer, with hepatology",
              "guideline_ids": [
                "GL-BAVENO-VII-2022",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Liver transplant evaluation",
              "cadence": "With decompensation or MELD-Na of 15 or more",
              "status": "not_indicated",
              "detail": "Compensated; MELD-Na 6",
              "guideline_ids": [
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis A vaccination, dose 2",
              "cadence": "Six months or more after dose 1",
              "status": "completed_today",
              "detail": "Given today; series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose control: A1c with sensor data",
              "cadence": "Every three months when therapy changes",
              "status": "completed_today",
              "detail": "A1c 6.3%; glucose management indicator 6.8%; fasting glucose 112 mg/dL",
              "observation_ids": [
                "OBS-A1C-V5",
                "OBS-GMI-V5",
                "OBS-GLU-V5"
              ],
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Diabetic eye examination",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "Done in June: no retinopathy",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-ADA-6-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Zoledronic acid",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "Given eleven weeks ago; next in nine months, after a calcium check",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of decompensation (ascites, encephalopathy, jaundice, bleeding)",
              "cadence": "Each visit in cirrhosis",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-AASLD-HCV-2026",
                "GL-AASLD-HCV-MON",
                "GL-AASLD-ASCITES-2021",
                "GL-AASLD-PH-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Falls and fracture risk",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No falls",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C)",
              "cadence": "Each visit in liver disease",
              "status": "completed_today",
              "detail": "AUDIT-C 0",
              "observation_ids": [
                "OBS-AUDITC-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-AASLD-ALD-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain score and function",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "4 of 10; walking 30 minutes",
              "observation_ids": [
                "OBS-PAIN-V5"
              ],
              "guideline_ids": [
                "GL-RAKOSKI-2018",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and when treatment changes",
              "status": "completed_today",
              "detail": "PHQ-9 3",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Preventive visit next month. Ultrasound with alpha-fetoprotein in February. Hepatology review with liver stiffness a year after cure. Call for abdominal swelling, black stools, vomiting of blood, confusion or yellow eyes",
          "guideline_ids": [
            "GL-AASLD-HCV-2026",
            "GL-AASLD-HCV-MON",
            "GL-AASLD-HCC-2023",
            "GL-BAVENO-VII-2022",
            "GL-AASLD-PH-2024",
            "GL-AASLD-ASCITES-2021",
            "GL-USPSTF-ALC-2018",
            "GL-AASLD-ALD-2019",
            "GL-RAKOSKI-2018",
            "GL-CDC-OPIOID-2022",
            "GL-ADA-4-2026",
            "GL-ADA-6-2026",
            "GL-ENDO-OSTEO-MEN-2012",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-09-21",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on the clinic's online form before the visit and reviewed with him by Dr. Rasmussen",
          "hpi": {
            "narrative": "Mr. Knievel is a 57-year-old retired stunt performer with compensated cirrhosis from hepatitis C, cured by 12 weeks of sofosbuvir-velpatasvir, who comes for his yearly preventive visit five weeks after the test that confirmed cure. He has had no alcohol since the start of treatment. He takes carvedilol 12.5 mg daily without dizziness, and had his zoledronic acid infusion in June without a reaction. His pain is about 4 of 10; he goes to the pool twice a week and walks 30 minutes on flat ground most days. He has had no falls since starting physical therapy. His glucose sensor shows no low readings. He has had no abdominal swelling, black stools, confusion or yellowing of the eyes.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 57"
              },
              {
                "label": "Liver",
                "value": "Hepatitis C cured; compensated cirrhosis; carvedilol; next surveillance ultrasound in February"
              },
              {
                "label": "Alcohol",
                "value": "None since the start of treatment"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 0"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good; better than in years"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy with appearances and travel; good support from family and friends"
            },
            {
              "domain": "Substance use",
              "finding": "No alcohol since February; never smoked; no drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Pool exercise twice a week; walks 30 minutes most days; some golf"
            },
            {
              "domain": "Nutrition",
              "finding": "Three meals and a late-evening snack; protein at each meal; less salt"
            },
            {
              "domain": "Sleep",
              "finding": "Six to seven hours; wakes with hip pain once a night"
            },
            {
              "domain": "Falls and home safety",
              "finding": "No falls since physical therapy; grab bars and a shower chair; cane on long walks"
            },
            {
              "domain": "Driving",
              "finding": "Drives in daytime; always wears a seat belt"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in all"
            },
            {
              "domain": "Smoke alarms and firearms",
              "finding": "Smoke alarms tested; no firearms at home"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better; no fever or weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No vision change; retinal examination in June normal"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing change or nosebleeds"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or vomiting blood"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary hesitancy, frequency or blood in the urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Hip, knee and back pain, about 4 of 10"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No yellowing, itching or new skin lesions"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion, sleep reversal or tremor"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low glucose readings"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 82.4 kg; blood pressure 122/74; pulse 62"
            },
            {
              "system": "Eyes",
              "finding": "No scleral icterus"
            },
            {
              "system": "Skin",
              "finding": "A few spider angiomas on the chest, fewer than before; palmar erythema; no jaundice"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Spleen tip palpable; no ascites or tenderness"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Reduced hip rotation on both sides; old fracture deformities of the forearms; knees with crepitus"
            },
            {
              "system": "Feet",
              "finding": "Monofilament sensation intact; pulses present; no ulcers"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis; gait slow but steady; Timed Up and Go 11 seconds"
            },
            {
              "system": "Psychiatric",
              "finding": "Cheerful and blunt"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Colorectal cancer screening is due at 57 and he has never been screened: colonoscopy ordered; carvedilol continues, and platelets of 134 do not stand in the way. Prostate cancer screening was discussed, including the chance of false positives and overtreatment, and he chose a PSA test: 1.3 ng/mL. Lipids on atorvastatin: LDL 68 mg/dL. Influenza, PCV20, the first recombinant zoster dose and Tdap given today; hepatitis A and B vaccine series are complete",
              "plan": [
                "Colonoscopy in the next two months",
                "Second zoster dose in two to six months",
                "COVID-19 vaccine this season",
                "Dental and eye examinations yearly",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Compensated cirrhosis after hepatitis C cure",
              "assessment": "No sign of decompensation; cirrhosis remains after cure, so liver cancer surveillance continues",
              "plan": [
                "Ultrasound with alpha-fetoprotein in February",
                "Continue carvedilol 12.5 mg daily",
                "No alcohol"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Type 2 diabetes",
              "assessment": "Glucose management indicator 6.8% a month ago; no hypoglycemia; foot examination normal",
              "plan": [
                "Continue metformin and the glucose sensor"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "122/74 mmHg on carvedilol",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0; PHQ-9 3 a month ago",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening and counseling",
              "status": "completed_today",
              "detail": "No alcohol since February; abstinence reinforced",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "Never screened; colonoscopy ordered",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "completed_today",
              "detail": "Shared decision; he chose testing; PSA 1.3 ng/mL",
              "guideline_ids": [
                "GL-USPSTF-PSA-2018"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Diabetes and lipid care",
              "status": "completed_today",
              "detail": "Glucose management indicator 6.8%; LDL 68 mg/dL on atorvastatin; urine albumin normal in January",
              "guideline_ids": [
                "GL-ADA-4-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Hepatitis C, hepatitis B and HIV screening",
              "status": "up_to_date",
              "detail": "Hepatitis C treated and cured; hepatitis B and HIV negative in January",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020",
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Liver cancer surveillance",
              "status": "up_to_date",
              "detail": "Ultrasound and alpha-fetoprotein in August; next in February",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "service": "Osteoporosis",
              "status": "up_to_date",
              "detail": "Zoledronic acid in June; bone density again in two years",
              "guideline_ids": [
                "GL-ENDO-OSTEO-MEN-2012",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Fall risk",
              "status": "completed_today",
              "detail": "No falls since physical therapy; Timed Up and Go 11 seconds",
              "guideline_ids": [
                "GL-PREV-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Influenza, pneumococcal, zoster and Tdap vaccines",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis A and B vaccines",
              "status": "up_to_date",
              "detail": "Both two-dose series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "due",
              "detail": "At his pharmacy this autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Dental and eye examinations",
              "status": "up_to_date",
              "detail": "Dental review before zoledronic acid in May; retinal examination in June",
              "guideline_ids": [
                "GL-PREV-2026",
                "GL-ADA-4-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment, including a liver transplant evaluation if his liver ever fails, and wants to be told plainly how he is doing. He named a health care agent, recorded in the confidential part of the chart and not named here. He chose not to complete other treatment preferences today. To be revisited yearly or if his health changes.",
          "follow_up": "Colonoscopy in the next two months. Liver ultrasound with alpha-fetoprotein in February. Hepatology review with liver stiffness a year after cure. Second zoster dose in two to six months. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-PSA-2018",
            "GL-USPSTF-ALC-2018",
            "GL-CDC-IMZ-2026",
            "GL-AASLD-HCC-2023",
            "GL-ADA-4-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-01-12",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 86.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 138,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-01-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 85.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-02-23",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 84.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-05-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 83.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 62,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-08-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 82.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 60,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-09-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 82.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 62,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the preventive visit, seated.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:30:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Retired motorcycle stunt performer; earns his living from public appearances, autographs and product endorsements; travels often",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to his documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Lives in Florida in the winter and Montana in the summer; four grown children",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": "Synthetic household; no relative is named or given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Alcohol: three or four drinks of whiskey or beer most evenings for many years, which he says helps him sleep through the pain; no drink-driving; willing to talk about cutting down",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic, sensitive. Anchored to the obituary report that he did not stop drinking until his 1999 transplant; the amount and pattern are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Tobacco: never smoked cigarettes; no drug use; no tattoos or shared needles; many blood transfusions after crashes in the 1960s and 1970s",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic risk history; the transfusions are anchored to the documented likely source of his hepatitis C.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Exercise: golf when his hips allow; walks short distances",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity history.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in daily activities; walks about two blocks before hip and knee pain stops him; uses a cane for long distances; two falls in the past year without injury",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, oriented, talkative and blunt; good humor about his injuries; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Raised transaminases (ALT 88, AST 96 U/L) and platelets of 118 on today's tests, with spider angiomas and palmar erythema, in a 57-year-old retired stunt performer who received many blood transfusions after crashes before 1992, drinks most evenings and has type 2 diabetes. Hepatitis C antibody with reflex RNA, hepatitis A and B serology, HIV and an abdominal ultrasound are ordered. Please see him within three weeks to confirm the cause, stage his liver disease and plan treatment",
        "urgency": "Within three weeks; sooner if he develops jaundice, ascites, bleeding or confusion",
        "pertinent_history": "Dozens of fractures from stunt crashes, including a broken pelvis, with many blood transfusions in the 1960s and 1970s. Three or four drinks most evenings for years (AUDIT-C 7); never smoked; no drug use. Type 2 diabetes on metformin, A1c 7.4%. Chronic back, hip and knee pain treated for years with ibuprofen 800 mg three times a day and omeprazole; both stopped today, with acetaminophen up to 2 g a day and diclofenac gel. Two falls in the past year without injury. Examination today: blood pressure 138/84, pulse 80; spider angiomas and palmar erythema; no jaundice, ascites or asterixis. Results today: hemoglobin 13.9 g/dL, platelets 118, creatinine 0.92 mg/dL, eGFR 97, ALT 88, AST 96, alkaline phosphatase 104 U/L, bilirubin 1.1 mg/dL, albumin 3.6 g/dL, INR 1.1, glucose 162 mg/dL, LDL 112 mg/dL. FIB-4 4.94. No known allergies. He wants to keep walking and does not want strong pain pills",
        "questions": [
          "Does he have chronic hepatitis C, and what is the stage of his liver disease?",
          "Which antiviral treatment do you recommend, and are there interactions with his medicines?",
          "Does he need endoscopy or treatment for portal hypertension?",
          "What surveillance does he need for liver cancer and other complications, and does he need a transplant evaluation?",
          "How should his pain, diabetes and alcohol use be managed safely with his liver disease?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Knievel, 57, is seen at the request of Dr. Rasmussen two weeks after raised transaminases and low platelets were found at his first visit. He received many transfusions after crashes during his stunt career, before blood was screened for hepatitis C. The hepatitis C antibody is positive with HCV RNA 2.35 million IU/mL, genotype 1a; he has never been treated. He drank three or four drinks most evenings and has cut down to about two since the first visit. He has type 2 diabetes on metformin and chronic pain from old fractures; ibuprofen and omeprazole were stopped two weeks ago. He has had no jaundice, abdominal swelling, black stools, vomiting of blood or confusion",
        "data_reviewed": "Dr. Rasmussen's intake note and results: platelets 118, ALT 88, AST 96 U/L, bilirubin 1.1 mg/dL, albumin 3.6 g/dL, INR 1.1, creatinine 0.92 mg/dL, eGFR 97, A1c 7.4%, LDL 112 mg/dL; FIB-4 4.94. Serology: HCV RNA 2.35 million IU/mL, genotype 1a; hepatitis B surface antigen, core antibody and surface antibody negative; hepatitis A IgG negative; HIV negative. Ultrasound a week ago: nodular liver, coarse echotexture, no focal lesion, spleen 14.2 cm, patent portal vein with forward flow, no ascites. Transient elastography in clinic today: 26.8 kPa (reliable), controlled attenuation parameter 248 dB/m",
        "exam": [
          {
            "system": "General",
            "finding": "Well; blood pressure 136/82, pulse 78"
          },
          {
            "system": "Skin",
            "finding": "Six spider angiomas; palmar erythema; no jaundice"
          },
          {
            "system": "Abdomen",
            "finding": "Firm liver edge 2 cm below the costal margin; spleen tip palpable; no shifting dullness"
          },
          {
            "system": "Neurological",
            "finding": "No asterixis"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Chronic hepatitis C, genotype 1a, treatment-naive",
            "assessment": "Chronic hepatitis C, almost certainly acquired through transfusions. He meets the AASLD-IDSA criteria for simplified treatment of compensated cirrhosis. I recommend sofosbuvir-velpatasvir, one tablet daily for 12 weeks; glecaprevir-pibrentasvir for 8 weeks would also be suitable but interacts strongly with atorvastatin, which he needs. He must not take a proton pump inhibitor during treatment; famotidine up to 40 mg twice a day is acceptable if needed. Hepatitis B tests are negative, so there is no reactivation risk. On-treatment liver tests are optional; glucose should be watched because control can improve quickly as the virus clears. Cure is confirmed by HCV RNA 12 or more weeks after the last dose"
          },
          {
            "problem_id": "PRB-003",
            "display": "Compensated cirrhosis, Child-Pugh A5, MELD-Na 8",
            "assessment": "FIB-4 4.94, liver stiffness 26.8 kPa, a nodular liver, splenomegaly and platelets of 118 establish cirrhosis; alcohol has added to the damage. It is compensated: Child-Pugh A5 and MELD-Na 8. He needs liver cancer surveillance by ultrasound with alpha-fetoprotein every six months for life, including after cure. He does not need a transplant evaluation now; I would refer him if he developed ascites, variceal bleeding, encephalopathy or jaundice, or a MELD-Na of 15. Stopping alcohol completely is the most important thing he can do alongside cure"
          },
          {
            "problem_id": "PRB-004",
            "display": "Clinically significant portal hypertension",
            "assessment": "Under Baveno VII, a liver stiffness of 25 kPa or more establishes clinically significant portal hypertension. Carvedilol lowers the risk of decompensation, and a patient taking it does not need screening endoscopy for varices, which would not change treatment. Start 6.25 mg daily and raise it to 12.5 mg if systolic pressure stays above 100. Reassess stiffness and platelets a year after cure"
          },
          {
            "problem_id": "PRB-005",
            "display": "Type 2 diabetes in cirrhosis",
            "assessment": "Metformin is appropriate in compensated cirrhosis with normal kidney function, provided he stops drinking. The A1c can read falsely low in cirrhosis, so a continuous glucose monitor is better for decisions. A moderate-intensity statin is safe and indicated"
          },
          {
            "problem_id": "PRB-006",
            "display": "Chronic pain from old fractures",
            "assessment": "Keep acetaminophen at or below 2 g a day; avoid oral NSAIDs, which can cause kidney injury, bleeding and fluid retention in cirrhosis; topical diclofenac on small areas is reasonable; avoid opioids, which can precipitate encephalopathy and falls; physical and aquatic therapy are the mainstay. His many old fractures and liver disease also put him at risk of osteoporosis, and a bone density scan is worthwhile"
          }
        ],
        "recommendations": [
          "Sofosbuvir 400 mg and velpatasvir 100 mg, one tablet daily for 12 weeks, once approved; no proton pump inhibitor during treatment; watch for muscle pain on atorvastatin; glucose monitoring for hypoglycemia",
          "HCV RNA and liver tests 12 or more weeks after the last dose",
          "Carvedilol 6.25 mg daily, raised to 12.5 mg daily if tolerated; no screening endoscopy while he takes it; liver stiffness and platelets a year after cure",
          "Ultrasound with alpha-fetoprotein every six months for life, next in July",
          "Hepatitis A and hepatitis B vaccination now (two doses each); pneumococcal, influenza and zoster vaccines in due course",
          "Complete abstinence from alcohol, with counseling or medicine if needed",
          "Teach the signs of decompensation and refer for transplant evaluation only if decompensation occurs or the MELD-Na reaches 15",
          "Atorvastatin 20 mg daily; metformin continued; continuous glucose monitoring; yearly eye examination",
          "Pain care without oral NSAIDs or opioids: acetaminophen up to 2 g a day, topical diclofenac, physical and aquatic therapy; bone density scan and vitamin D level"
        ],
        "communication": "Discussed with Dr. Rasmussen, who saw him the same day. The diagnosis, the stage of his liver disease and the plan were explained to Mr. Knievel, who agreed to treatment and to stop drinking",
        "follow_up": "Hepatology review at the end of treatment and with liver stiffness a year after cure; Dr. Rasmussen continues primary care, starts carvedilol and the vaccines today, and arranges surveillance"
      },
      "guideline_ids": [
        "GL-AASLD-HCV-2026",
        "GL-AASLD-HCV-MON",
        "GL-EPCLUSA-LABEL",
        "GL-AASLD-HCC-2023",
        "GL-BAVENO-VII-2022",
        "GL-AASLD-PH-2024",
        "GL-AASLD-ASCITES-2021",
        "GL-AASLD-ALD-2019",
        "GL-RAKOSKI-2018",
        "GL-ADA-6-2026",
        "GL-ENDO-OSTEO-MEN-2012",
        "GL-CDC-IMZ-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Pain in the back, hips and knees every day from old fractures, worse in the morning and after travel; ibuprofen three times a day for years",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic presenting concern anchored to his documented injuries.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "Tired for months; noticed small red spots on his chest and wonders whether the old transfusions or his drinking have hurt his liver",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting concern; no symptom of his real illness was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He wants to keep walking and playing golf and does not want to depend on strong pain pills",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "HC-004",
        "display": "Two falls in the past year; he worries about breaking another bone",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic concern anchored to his documented fracture history.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Hepatitis C confirmed or excluded and liver disease staged within three weeks",
        "status": "completed",
        "target_date": "2026-01-26",
        "outcome": "Chronic hepatitis C, genotype 1a, with compensated cirrhosis staged at two weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Cure of hepatitis C: HCV RNA not detected 12 or more weeks after treatment",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "HCV RNA not detected 13 weeks after a 12-week course",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antiviral goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "No decompensation (ascites, variceal bleeding, encephalopathy or jaundice); Child-Pugh A and MELD-Na below 15",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "No decompensation; Child-Pugh A5; MELD-Na 6 after cure",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "No alcohol",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "No alcohol since the start of antiviral treatment; AUDIT-C 0",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic, sensitive alcohol goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Pain 4 of 10 or less, walking 30 minutes, with no oral NSAIDs or opioids",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "Pain 4 of 10; walking 30 minutes in the pool and on flat ground; no NSAIDs or opioids",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Glucose management indicator below 7% without hypoglycemia",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "Glucose management indicator 6.8%; no hypoglycemia",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diabetes goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-007",
        "display": "Vitamin D replete and osteoporosis treatment started; no falls with injury",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "Vitamin D 34 ng/mL; zoledronic acid given; no further falls",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic bone and falls goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Hepatology consultation within three weeks to confirm and stage chronic liver disease and plan antiviral treatment if hepatitis C is confirmed",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-HCV-2026",
          "GL-AASLD-HCC-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation booked at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Liver work-up for raised transaminases and low platelets: hepatitis C antibody with reflex RNA, hepatitis B surface antigen, core antibody and surface antibody, hepatitis A IgG, HIV, INR, ultrasound of the abdomen, and FIB-4 from today's tests",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-HCV-2026",
          "GL-USPSTF-HCV-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Pain care safe in liver disease: stop ibuprofen and omeprazole; acetaminophen up to 2 g a day; topical diclofenac for the knees; no opioids; physical and aquatic therapy; heat, pacing and sleep routines; pain coping skills",
        "status": "completed",
        "guideline_ids": [
          "GL-RAKOSKI-2018",
          "GL-CDC-OPIOID-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic pain plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Alcohol: brief counseling toward stopping completely, because alcohol speeds liver scarring; follow-up AUDIT-C at each visit; counseling or medicine for alcohol use offered if he cannot stop",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-ALC-2018",
          "GL-AASLD-ALD-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic, sensitive plan anchored to the obituary report of his drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Sofosbuvir-velpatasvir one tablet daily for 12 weeks under the AASLD-IDSA simplified pathway for compensated cirrhosis, after hepatitis B testing and a drug interaction check (no proton pump inhibitor; watch for muscle pain on atorvastatin); glucose monitoring for hypoglycemia; HCV RNA and liver tests 12 or more weeks after the last dose",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-HCV-2026",
          "GL-AASLD-HCV-MON",
          "GL-EPCLUSA-LABEL"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic antiviral plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-01-26"
      },
      {
        "id": "INT-006",
        "display": "Carvedilol for clinically significant portal hypertension (liver stiffness 25 kPa or more), started at 6.25 mg and raised to 12.5 mg daily if blood pressure allows; no screening endoscopy while he takes it; liver stiffness and platelets rechecked a year after cure",
        "status": "completed",
        "guideline_ids": [
          "GL-BAVENO-VII-2022",
          "GL-AASLD-PH-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic portal hypertension plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-01-26"
      },
      {
        "id": "INT-007",
        "display": "Liver cancer surveillance by ultrasound with alpha-fetoprotein every six months, continuing after cure because cirrhosis remains",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-HCC-2023",
          "GL-AASLD-HCV-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic surveillance plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-01-26"
      },
      {
        "id": "INT-008",
        "display": "Vaccines for chronic liver disease: hepatitis A (two doses) and hepatitis B (two doses), then influenza, pneumococcal and zoster vaccines at the preventive visit",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-2026",
          "GL-AASLD-HCV-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-01-26"
      },
      {
        "id": "INT-009",
        "display": "Teaching on decompensation (swelling of the abdomen or legs, black stools or vomiting blood, confusion, yellow eyes) with same-day contact; transplant referral only if decompensation occurs or the MELD-Na reaches 15",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-ASCITES-2021",
          "GL-AASLD-PH-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic safety plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-01-26"
      },
      {
        "id": "INT-010",
        "display": "Diabetes care adapted to cirrhosis: metformin continued while kidney function is normal and he does not drink; continuous glucose monitoring because the A1c can read falsely low; moderate-intensity statin; yearly eye and foot examinations and urine albumin",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-4-2026",
          "GL-ADA-6-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diabetes plan decided once cirrhosis was found.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-01-26"
      },
      {
        "id": "INT-011",
        "display": "Falls and fractures: physical therapy and a home safety review; vitamin D; bone density scan, since cirrhosis, alcohol and many old fractures raise the risk of osteoporosis",
        "status": "completed",
        "guideline_ids": [
          "GL-ENDO-OSTEO-MEN-2012",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic falls and bone plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      },
      {
        "id": "INT-012",
        "display": "Zoledronic acid 5 mg intravenously once a year, after vitamin D repletion and a normal calcium, rather than an oral bisphosphonate because of portal hypertension; dental review first; bone density again in two years",
        "status": "completed",
        "guideline_ids": [
          "GL-ENDO-OSTEO-MEN-2012",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic osteoporosis treatment decided after the bone density result.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        },
        "recorded_date": "2026-05-18"
      },
      {
        "id": "INT-013",
        "display": "Depression and distress screening at each visit, and plain explanations with written information",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T23:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-AASLD-HCV-2026",
        "title": "AASLD-IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Simplified HCV treatment algorithm for treatment-naive adults with compensated cirrhosis",
        "publisher": "American Association for the Study of Liver Diseases and Infectious Diseases Society of America",
        "url": "https://www.hcvguidelines.org/guidance/simplified-hcv-treatment-algorithm-for-treatment-naive-adults-with-compensated-cirrhosis/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AASLD-HCV-MON",
        "title": "AASLD-IDSA HCV Guidance: Monitoring patients who are starting HCV treatment, are on treatment, or have completed therapy",
        "publisher": "American Association for the Study of Liver Diseases and Infectious Diseases Society of America",
        "url": "https://www.hcvguidelines.org/guidance/monitoring-patients-who-are-starting-hcv-treatment-are-on-treatment-or-have-completed-therapy/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-EPCLUSA-LABEL",
        "title": "EPCLUSA (sofosbuvir and velpatasvir) tablets, prescribing information",
        "publisher": "U.S. National Library of Medicine, DailyMed (Gilead Sciences label)",
        "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f30631a-ee3b-4cfe-866b-964df3f0a44f",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-AASLD-HCC-2023",
        "title": "Singal AG, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 2023;78(6):1922-1965 (PMID 37199193)",
        "publisher": "American Association for the Study of Liver Diseases",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37199193/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-BAVENO-VII-2022",
        "title": "de Franchis R, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022;76(4):959-974 (PMID 35120736)",
        "publisher": "Baveno VII Faculty (Journal of Hepatology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35120736/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-AASLD-PH-2024",
        "title": "Kaplan DE, et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024;79(5):1180-1211 (PMID 37870298)",
        "publisher": "American Association for the Study of Liver Diseases",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37870298/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-AASLD-ASCITES-2021",
        "title": "Biggins SW, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the AASLD. Hepatology 2021;74(2):1014-1048 (PMID 33942342)",
        "publisher": "American Association for the Study of Liver Diseases",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33942342/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-AASLD-ALD-2019",
        "title": "Crabb DW, et al. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the AASLD. Hepatology 2020;71(1):306-333 (PMID 31314133)",
        "publisher": "American Association for the Study of Liver Diseases",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31314133/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-RAKOSKI-2018",
        "title": "Rakoski M, Goyal P, Spencer-Safier M, et al. Pain management in patients with cirrhosis. Clin Liver Dis (Hoboken) 2018;11(6):135-140 (PMID 30992804)",
        "publisher": "American Association for the Study of Liver Diseases (Clinical Liver Disease)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/30992804/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-OPIOID-2022",
        "title": "Dowell D, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022;71(3):1-95 (PMID 36327391)",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36327391/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ADA-4-2026",
        "title": "American Diabetes Association. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Suppl 1):S61-S88 (PMID 41358897)",
        "publisher": "American Diabetes Association",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358897/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-6-2026",
        "title": "American Diabetes Association. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Suppl 1):S132-S149 (PMID 41358894)",
        "publisher": "American Diabetes Association",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358894/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ENDO-OSTEO-MEN-2012",
        "title": "Watts NB, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97(6):1802-1822 (PMID 22675062)",
        "publisher": "Endocrine Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/22675062/",
        "version_or_year": "2012"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, diabetes type 2, osteoporosis and depression monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PSA-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the diagnostic pathway, the staging (FIB-4, elastography, Child-Pugh, MELD-Na), the choice of sofosbuvir-velpatasvir with the drug interaction check, carvedilol without screening endoscopy under Baveno VII, HCC surveillance after cure, the pain plan without NSAIDs or opioids, continuous glucose monitoring in cirrhosis, and zoledronic acid rather than an oral bisphosphonate."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what he made public, what was reported during his life, and obituaries and record-keeper accounts: the Associated Press, ESPN, Reuters, the Deseret News and Guinness World Records. The stage of his liver disease and any treatment before the 1999 transplant were not made public; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "The drinking reported in a Reuters obituary (CLM-0006) and the drug pump for pain in his last year (CLM-0008) are marked sensitive. No diagnosis of an alcohol or opioid use disorder is made; alcohol appears only as counseling and AUDIT-C scores, which are synthetic. Mood screens are synthetic and below the threshold for a safety assessment. His 1977 conviction is not medical and is left out. No relative is named or given a role."
    }
  }
}
